These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11584358)

  • 21. [Expression of cyclooxygenase in bladder transitional cell carcinoma].
    Wang KJ; Li H; Wei Q; Yang YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells.
    Bottone FG; Martinez JM; Alston-Mills B; Eling TE
    Carcinogenesis; 2004 Mar; 25(3):349-57. PubMed ID: 14633654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
    J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells.
    Nzeako UC; Guicciardi ME; Yoon JH; Bronk SF; Gores GJ
    Hepatology; 2002 Mar; 35(3):552-9. PubMed ID: 11870367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase-2 expression during carcinogenesis in the human stomach.
    van Rees BP; Saukkonen K; Ristimäki A; Polkowski W; Tytgat GN; Drillenburg P; Offerhaus GJ
    J Pathol; 2002 Feb; 196(2):171-9. PubMed ID: 11793368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
    Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis.
    Yoon JH; Canbay AE; Werneburg NW; Lee SP; Gores GJ
    Hepatology; 2004 Mar; 39(3):732-8. PubMed ID: 14999691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of cyclooxygenase-2 in patients with bladder carcinoma.
    Yoshimura R; Sano H; Mitsuhashi M; Kohno M; Chargui J; Wada S
    J Urol; 2001 May; 165(5):1468-72. PubMed ID: 11342898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells.
    Liu CY; Lai YY; Lo CJ
    J Surg Res; 2004 Apr; 117(2):223-31. PubMed ID: 15047127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas].
    Wang HX; Chen QK
    Ai Zheng; 2003 Jun; 22(6):649-52. PubMed ID: 12948419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression.
    Elder DJ; Baker JA; Banu NA; Moorghen M; Paraskeva C
    J Pathol; 2002 Dec; 198(4):428-34. PubMed ID: 12434411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers.
    Koki AT; Khan NK; Woerner BM; Seibert K; Harmon JL; Dannenberg AJ; Soslow RA; Masferrer JL
    Prostaglandins Leukot Essent Fatty Acids; 2002 Jan; 66(1):13-8. PubMed ID: 12051953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase-2 expression in human esophageal carcinoma.
    Zimmermann KC; Sarbia M; Weber AA; Borchard F; Gabbert HE; Schrör K
    Cancer Res; 1999 Jan; 59(1):198-204. PubMed ID: 9892207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis.
    Cornetta AJ; Russell JP; Cunnane M; Keane WM; Rothstein JL
    Laryngoscope; 2002 Feb; 112(2):238-42. PubMed ID: 11889377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection.
    Okajima E; Uemura H; Ohnishi S; Tanaka M; Ohta M; Tani M; Fujimoto K; Ozono S; Okajima E; Hirao Y
    Aktuelle Urol; 2003 Jul; 34(4):256-8. PubMed ID: 14566678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
    Lin J; Hsiao PW; Chiu TH; Chao JI
    Biochem Pharmacol; 2005 Sep; 70(5):658-67. PubMed ID: 16004971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of cyclooxygenase-1 and -2 in extra-hepatic cholangiocarcinoma.
    Wu GS; Wang JH; Liu ZR; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):429-33. PubMed ID: 14607721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.